“In more than half the countries in the world, there is no excess mortality until the vaccines are rolled out, and then there is a significant shift to a domain of higher mortality.” ~ Denis Rancourt
We are delighted to honor Canadian physicist and interdisciplinary scientist Denis Rancourt as our Hero of the Week. Rancourt currently co-directs CORRELATION Research in the Public Interest, a registered non-profit dedicated to conducting independent scientific research on topics of public concern.
Rancourt possesses BSc, MSc, and PhD degrees in physics and conducted post-doctoral research at renowned institutions in France and the Netherlands. Following this, he served as a physics professor and lead scientist at the University of Ottawa for more than two decades.
Over the course of his career, Rancourt has authored more than 100 peer-reviewed journal articles in science and technology, along with over 30 scientific reports related to Covid. Currently, he focuses his research and writing in areas such as medicine, Covid-19, health, geopolitics, civil rights, political theory, and sociology.
In September 2023, Rancourt co-authored the paper titled “COVID-19 vaccine-associated mortality in the Southern Hemisphere.” The 17-country analysis found no evidence that the Covid jabs had reduced overall deaths within those countries, instead showing the exact opposite—a stark rise in all-cause mortality after the Covid “vaccine” rollout. The implications of this analysis, the authors note, are that “the global COVID-19 vaccination campaign was in effect a mass iatrogenic event” that killed an estimated 17 million people worldwide.
You can follow Dr. Rancourt’s latest articles, posts, and findings on Substack.
Related:
Denis Rancourt (website)
COVID-19 vaccine-associated mortality in the Southern Hemisphere (September 17, 2023)
There Was No Pandemic (first Substack essay, July 2, 2023)
All Cause Mortality with Denis Rancourt, Ph.D. (The Defender Show with Robert F. Kennedy, Jr., January 24, 2023)
CORRELATION Research in the Public Interest
